ID

26167

Descrizione

Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 End of Re-Enrollment Titration Period

Keywords

versioni (1)
  1. 10/10/17 10/10/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

10 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC-ND 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

Inglese

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

1 moduli  
Patient Information
Descrizione

Patient Information

Alias
UMLS CUI-1
C1955348
Patient No.
Descrizione

Patient Number

Tipo di dati

text

Alias
UMLS CUI [1]
C1830427
Date of Visit
Descrizione

Date of Visit

Tipo di dati

date

Unità di misura
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1320303
dd-mmm-yyyy
End of Re-Enrollment Titration Period
Descrizione

End of Re-Enrollment Titration Period

Alias
UMLS CUI-1
C1516879
UMLS CUI-2
C1272693
UMLS CUI-3
C2983683
Dose of Study Medication prescribed for Maintenance period:
Descrizione

Dosage of study drug

Tipo di dati

float

Unità di misura
  • mg/d
Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
mg/d
At which week did Titration end?
Descrizione

End Date of Titration

Tipo di dati

float

Unità di misura
  • week
Alias
UMLS CUI [1,1]
C2983683
UMLS CUI [1,2]
C0806020
week
Investigator Signature
Descrizione

Investigator Signature

Alias
UMLS CUI-1
C2346576
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
Descrizione

Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C1519316
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
Descrizione

Investigator's Name

Tipo di dati

text

Alias
UMLS CUI [1]
C2826892
Date
Descrizione

Date of Report

Tipo di dati

date

Unità di misura
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1302584
dd-mmm-yyyy
Ritorna all'inizio della pagina

Similar models

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient No.
text
C1830427 (UMLS CUI [1])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item Group
End of Re-Enrollment Titration Period
C1516879 (UMLS CUI-1)
C1272693 (UMLS CUI-2)
C2983683 (UMLS CUI-3)
Dosage of study drug
Item
Dose of Study Medication prescribed for Maintenance period:
float
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
End Date of Titration
Item
At which week did Titration end?
float
C2983683 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Investigator Signature
C2346576 (UMLS CUI-1)
Signature
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
text
C1519316 (UMLS CUI [1])
Investigator's Name
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
text
C2826892 (UMLS CUI [1])
Date of Report
Item
Date
date
C1302584 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial